EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Hydrogel-based fluorescence assay kit for simultaneous determination of ceftazidime and avibactam

Xiaoli Wang, Linyu Du, Boshun Zhang, Yingchun Li, Zheying Tao, Li Zhang, Jieming Qu, Johnjoe McFadden, Hongping Qu, Jiao Yang, Jialin Liu

Microchimica Acta · 2024

DOI: 10.1007/s00604-024-06742-1 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microchimica Acta, 2024. Verfasst von Xiaoli Wang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Critical Care Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China. Hauptthemen laut MEDLINE: Azabicyclo Compounds, Ceftazidime, Quantum Dots, Anti-Bacterial Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Key R&D Program of China, National Research Center for Translational Medicine at Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, academic leader of health of Shanghai Municipal Health Commission.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Monitoring the concentration of antibiotics rapidly and cost-effectively is crucial for accurate clinical medication and timely identification of drug-induced illnesses. Here, we constructed a novel fluorescent assay kit to monitor Zavicefta, an effective antibiotic composed of avibactam (AVI) and ceftazidime (CFZ) to treat carbapenem-resistant gram-negative bacteria infections. AVI can emit fluorescence, but CFZ cannot. To enable simultaneous measurement of both in one kit, we designed molecularly imprinted polymer (MIP) modified quantum dots (QDs) for CFZ determination. MIPs have received significant attention as an artificial antibody due to their exceptional specificity for various targets, particularly drugs with small molecular weight. Under the excitation wavelength of 350 nm, the detection process involves a decrease in QDs' fluorescence signal at 600 nm owing to the "gate effect" between MIP and CFZ and the internal filtration effect between CFZ and QDs. Simultaneously, a fluorescence emission characteristic peak at 420 nm for AVI emerges. In addition, to simplify the operation procedure and improve determination throughput, the detection agents were incorporated into a hydrogel and placed in a 96-well plate, enabling concurrent quantification of AVI and CFZ within the respective range of 80-1000 μM and 1-1000 μM. The developed assay kit successfully determined AVI and CFZ in human serums and therapeutic drug monitoring in a live rabbit model. Recoveries of AVI and CFZ were 92.7-114%, with relative standard deviations below 6.0%. Moreover, a smartphone was employed to read the fluorescence signals, which was beneficial for cost reduction and out-of-lab analysis. This study will deliver a pragmatic resolution to developing high-throughput assay kits for drug determination.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Azabicyclo CompoundsCeftazidimeQuantum DotsAnti-Bacterial AgentsHydrogelsSpectrometry, FluorescenceDrug CombinationsMolecularly Imprinted PolymersAnimalsLimit of DetectionHumansFluorescence

Stichwörter der Autor:innen

AntibioticsFluorescence assay kitHydrogelMolecularly imprinted polymerQuantum dotTherapeutic drug monitoring

Substanzen

Azabicyclo CompoundsCeftazidimeAnti-Bacterial AgentsHydrogelsavibactam, ceftazidime drug combinationDrug CombinationsMolecularly Imprinted Polymers

Autor:innen und Institutionen

  • Department of Critical Care Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.
  • School of Science, Harbin Institute of Technology, Shenzhen, 518055, China.
  • Department of Geriatric Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.
  • Department of Pulmonary and Critical Care Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.
  • Faculty of Health and Medical Sciences, School of Biosciences and Medicine, University of Surrey, Guildford, UK.
  • Department of Critical Care Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China. hongpingqu0412@hotmail.com.

Förderung

  • National Key R&D Program of China
  • National Research Center for Translational Medicine at Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
  • academic leader of health of Shanghai Municipal Health Commission
  • Science and Technology Commission of Shanghai Municipality
  • Innovate United Kingdom

Zitieren

APA

Wang, X., Du, L., Zhang, B., Li, Y., Tao, Z., Zhang, L., Qu, J., McFadden, J., Qu, H., Yang, J., & Liu, J. (2024). Hydrogel-based fluorescence assay kit for simultaneous determination of ceftazidime and avibactam. Microchimica Acta. https://doi.org/10.1007/s00604-024-06742-1

Vancouver

Wang X, Du L, Zhang B, Li Y, Tao Z, Zhang L, et al. Hydrogel-based fluorescence assay kit for simultaneous determination of ceftazidime and avibactam. Microchimica Acta. 2024. doi:10.1007/s00604-024-06742-1

BibTeX
@article{Wang2024,
  author = {Wang, Xiaoli and Du, Linyu and Zhang, Boshun and Li, Yingchun and Tao, Zheying and Zhang, Li and Qu, Jieming and McFadden, Johnjoe and Qu, Hongping and Yang, Jiao and Liu, Jialin},
  title = {Hydrogel-based fluorescence assay kit for simultaneous determination of ceftazidime and avibactam},
  journal = {Microchimica Acta},
  year = {2024},
  doi = {10.1007/s00604-024-06742-1}
}
Kostenlos starten →